Boehringer Ingelheim and EMRI: Transforming Pre-Hospital Stroke CareBoehringer Ingelheim India and EMRI Green Health Services—a GVK enterprise operating the 108 National Emergency Ambulance Service—have signed a landmark Memorandum of Understanding (MoU) to enhance pre-hospital stroke care across 14 states and Union Territories.
on
February 12, 2025
India Steps Up Fight Against Filariasis: JP Nadda Launches Nationwide Mass Drug Campaign
on
Novel TIMP1-CD63 Pathway: A Potential Therapeutic Breakthrough in Pancreatic CancerIn a promising development for pancreatic cancer treatment, scientists at National Chung Cheng University (CCU) and National Cheng Kung University (NCKU) in Taiwan have identified a previously unknown signaling mechanism that helps KRAS-mutated pancreatic cancer cells, which account for up to 90% of cases evade immune destruction. Their study also shows that a deficiency in the dual-specificity phosphatase-2 (DUSP2) gene allows these malignant cells to sustain unchecked growth.
on
February 10, 2025
ICMR Leads Mission to Develop India’s First H5N1 Vaccine for HumansIn a significant move to tackle the rising threat of avian influenza, the Indian Council of Medical Research (ICMR) has initiated the development of an indigenous vaccine against the H5N1 virus. India has witnessed multiple H5N1 outbreaks since 2021, affecting both poultry and wild birds. Healthcare experts warn that if the virus mutates to enable human-to-human transmission, it could potentially trigger a global pandemic.
on
February 8, 2025
Novel 'Self-Actuating' Rheumatoid Arthritis Therapy Shows Promise for On-Demand Drug ReleaseResearchers at the Institute of Nano Science and Technology (INST) Mohali, under the Department of Science and Technology, have pioneered a "self-actuating" drug delivery system that directly targets joint inflammation. This approach not only minimizes systemic side effects but also reduces dosing frequency, signaling a major leap forward in Rheumatoid Arthritis (RA) therapy.
on
February 7, 2025

Featured

FDA Approves Blujepa (Gepotidacin): First New Oral Antibiotic for uUTIs in Nearly 30 Years
Lorundrostat Shows Promise in Treating Uncontrolled Hypertension in Pivotal Trials
Kerala School Reports Viral Meningitis Cases, Health Authorities on High Alert
DCGI’s Renewed Mandate: Wiping Out Substandard Drugs, Supporting MSMEs, and Regulating Medical Devices
Delhi Sees Surge in H1N1 and Influenza B Cases

Participate in India’s healthcare revolution

Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)

Create ABHA ID

Popular topics

#

newfeature

#

Partnership

#

funding